移动站  | 
银河线路检测中心

当前位置:首页  新闻公告  全部

2012年10月19日转化医学研究院学术报告

发布日期:2012年10月12日 11:52 来源:银河线路检测中心
打印 | 关闭
阅读次数:2453
报告时间:2012.10.19. 下午3点
地点:医学综合楼205会议室
主持人:许正平教授
报告人:Marcos Milla
题目:An Overview of Early Drug Discovery in Immunology at Janssen
报告人简介:Marcos Milla obtained his Bachelor’s degree in Biology from Universidad Peruana Cayetano Heredia, Lima, Peru. He then traveled to the USA, where he first obtained his PhD degree in Cell & Molecular Biology from Saint Louis University under the direction of Carlos Hirschberg, working on the mechanism of protein glycosylation in the secretory pathway. After graduating, he became a Jane Coffin Childs Postdoctoral Fellow at the Massachusetts Institute of Technology, working under the supervision of Robert Sauer on protein folding, performing the first alanine scan on a protein, bacteriophage P22 Arc, to understand the relationship between its amino acid sequence and its folding, structural stability and DNA binding function. Then he did a short second postdoctoral training at Duke University, working with Christian Raetz on the biosynthetic pathway of bacterial lipid A. As an independent scientist, he worked first for 3 years at GlaxoSmithKline, participating in the discovery of the TNF-alpha converting enzyme (TACE) and cloning of its cDNA. After that, he joined the Faculty of the Department of Biochemistry and Biophysics of University of Pennsylvania, keeping a focus on TNF biology, proteases and protein-protein interactions. In 2005 he joined Roche Pharmaceuticals, where he led efforts in support of multiple projects in the areas of immunology and neurosciences. Since joining Janssen Pharmaceutical Research & Development in 2009, he led projects within the Immunology Therapeutic Area in early validation, lead discovery or optimization stage. Additionally, he is interested in exploratory research focusing on protein-protein interactions, and the application of “omic” approaches to disease understanding and drug discovery.
 
报告人:Jiao Song
题目:Simplifying Immune Response Quantitation with Mass Spectrometry  
  - High-Throughput Lipidomic Analysis of Eicosanoids
报告人简介:
Aug, 2005- Oct 2010: Medicinal Chemistry and Molecular Pharmacology in Purdue University.
Thesis title: Development of mass spectrometric tools for the cellular characterization of protein prenylation
Nov 2010- Jul 2012: Postdoctoral Fellow in Immunology, Drug Discovery, Janssen R&D, Pharmaceutical Companies of Johnson and Johnson
Projects: development of high-throughput mass spectrometry-based method for the quantitative characterization of chemokines and cytokines; development of highthroughput platform for lipidomic analysis of eicosaoinds.
Jul 2012 – present: Scientist, CREATe (Community of research excellence and advanced technology) - Core technology- Analytical Sciences, Janssen R&D
Analytical R&D support for various therapeutic areas (immunology, neuroscience, CVM (cardiovascular metabolisms)
打印 | 关闭